Skip to main content
. Author manuscript; available in PMC: 2014 May 6.
Published in final edited form as: Mol Pharm. 2013 Apr 24;10(5):1988–1997. doi: 10.1021/mp400007k

Figure 1.

Figure 1

EPR-mediated passive targeting and subsequent receptor-mediated cell-specific active targeting of the drug (e.g. photosensitizer Pc 4) nanoformulation in tumor; the cancer cells can subsequently undergo PDT-induced death upon photoirradiation.